Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

New bowel cancer screening test demonstrates major increase in participation rates

A large pilot study of a new bowel cancer screening test has demonstrated a major increase in participation rates across population groups.

31 Mar 2015

Researchers identify bio-markers that could help detect early stage colorectal cancer

Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European oncology centers, including UZ Leuven - have identified bio-markers that can be incorporated in a new diagnostic test.

30 Mar 2015

Moffitt researchers use integrative approaches to study cancer heterogeneity

Moffitt Cancer Center researchers are using integrative approaches to study cancer by combining mathematical and computational modeling with experimental and clinical data. The use of integrative approaches enables scientists to study and model cancer progression in a manner that conventional experimental systems are unable to do.

29 Mar 2015

Study: Blood test can help identify bowel cancer patients who may benefit from chemotherapy

Manchester researchers have provided early evidence to suggest that a blood test could be used to identify bowel cancer patients that may benefit from more intensive chemotherapy.

25 Mar 2015

Cancer-specific mortality lower in Asian Americans than non-Hispanic whites, shows study

Numerous studies have documented racial differences in deaths from cancer among non-Hispanic whites and African Americans, but little has been known about survival outcomes for Asian Americans who have been diagnosed with cancer, until now.

24 Mar 2015

Vitamin D3 and metformin show promising results in preventing colorectal cancer

The concept was simple: If two compounds each individually show promise in preventing colon cancer, surely it's worth trying the two together to see if even greater impact is possible.

24 Mar 2015

How our DNA may prevent bowel cancer

The link between taking aspirin, and similar medications called non-steroidal anti-inflammatory drugs (or NSAIDS), and bowel (colorectal) cancer prevention is well established.

23 Mar 2015

New strategies to improve screening rates for colorectal cancer in low-income populations

Since the colonoscopy was developed more than four decades ago, the screening procedure for colorectal cancer has undoubtedly saved millions of lives.

20 Mar 2015

BCM-95 Curcumin improves chemotherapy's effectiveness in killing chemoresistant cancer cells

Cancer cell resistance to chemotherapy is a major cause of death in patients with colorectal cancer. In a first-of-its-kind study, BCM-95 Curcumin was found to improve chemotherapy's effectiveness in killing chemoresistant cells via a mechanism not previously identified.

19 Mar 2015

New diagnostic method replaces surgery for bowel tumor assessment

A new study at the MedUni Vienna's Comprehensive Cancer Center is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.

19 Mar 2015

Genetic markers may help decide who benefits from aspirin, NSAIDs in lowering risk of colorectal cancer

An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.

18 Mar 2015

Penn researchers find evidence of new culprit in colon cancer

Colon cancer is a heavily studied disease -- and for good reason. It is one of the leading causes of cancer-related deaths worldwide, and its numbers are on the rise, from 500,00 deaths in 1990 to 700,000 in 2010.

17 Mar 2015

Parenchymal preservation surgery linked to lower mortality, complication rates in cancer patients

A surgical approach in which a surgeon removes less than a lobe of the liver in a patient undergoing an operation for liver cancer is associated with lower mortality and complication rates, according to new study results published online as an "article in press" in the Journal of the American College of Surgeons (JACS).

13 Mar 2015

TNMNews examines how cannabis laws impact students, families

The latest segment of TNMNews, the unbiased marijuana talk radio program from DigiPath, Inc., focuses on how laws based on the War on Drugs have hurt students and families.

13 Mar 2015

Kalorama Information: Budding market for digital PCR reached 175 million in 2014

Kalorama Information estimated the budding market for digital PCR reached 175 million in 2014. The market research publisher said companies will be looking to provide products to increase research and diagnostics in diseases like cancer and neurological disorders.

13 Mar 2015

ERC project aims to identify new treatments for prostate cancer

The European Research Council (ERC) has awarded a Consolidator Grant to ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Lab at the Institute for Research in Biomedicine (IRB Barcelona).

13 Mar 2015

Norgine partners with Arc Medical to commercialize and distribute ENDOCUFF VISION

Norgine and Arc Medical Design Ltd. today announced a partnership that will see Norgine commercialising and distributing ENDOCUFF VISION, a Class 1 sterile medical device used in colonoscopy, across a number of major European markets, Australia and New Zealand. Norgine's first launch of ENDOCUFF VISION will take place in the UK Q2 2015.

12 Mar 2015

Single-site laparoscopic surgery effective for colorectal cancer

Colorectal cancer may be highly preventable, yet it is second only to lung cancer in the number of lives it takes nationwide each year.

6 Mar 2015

Pre-clinical data on Novogen’s Cantrixil to be presented at two upcoming conferences

Novogen today announces that Professor Gil Mor MD PhD from Yale Medical School will be presenting pre-clinical data on the lead candidate product, Cantrixil, at two upcoming conferences.

6 Mar 2015

VolitionRx begins pilot study to assess feasibility of NuQ assays in detecting prostate cancer

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has initiated a pilot study to assess the feasibility of VolitionRx's proprietary NuQ assays in detecting prostate cancer.

5 Mar 2015

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

New bowel cancer screening test demonstrates major increase in participation rates

Researchers identify bio-markers that could help detect early stage colorectal cancer

Moffitt researchers use integrative approaches to study cancer heterogeneity

Study: Blood test can help identify bowel cancer patients who may benefit from chemotherapy

Cancer-specific mortality lower in Asian Americans than non-Hispanic whites, shows study

Vitamin D3 and metformin show promising results in preventing colorectal cancer

How our DNA may prevent bowel cancer

New strategies to improve screening rates for colorectal cancer in low-income populations

BCM-95 Curcumin improves chemotherapy's effectiveness in killing chemoresistant cancer cells

New diagnostic method replaces surgery for bowel tumor assessment

Genetic markers may help decide who benefits from aspirin, NSAIDs in lowering risk of colorectal cancer

Penn researchers find evidence of new culprit in colon cancer

Parenchymal preservation surgery linked to lower mortality, complication rates in cancer patients

TNMNews examines how cannabis laws impact students, families

Kalorama Information: Budding market for digital PCR reached 175 million in 2014

ERC project aims to identify new treatments for prostate cancer

Norgine partners with Arc Medical to commercialize and distribute ENDOCUFF VISION

Single-site laparoscopic surgery effective for colorectal cancer

Pre-clinical data on Novogen’s Cantrixil to be presented at two upcoming conferences

VolitionRx begins pilot study to assess feasibility of NuQ assays in detecting prostate cancer

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in